United States· US:62756-427_4ba06043-b13f-42fe-a398-fe7e7b84163e
Ciprofloxacin and dexamethasone
A medicinal product containing ciprofloxacin hydrochloride; dexamethasone, registered in United States by Sun Pharmaceutical Industries, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162756-427-90
- ndc1162756427901 BOTTLE, DROPPER in 1 CARTON (62756-427-90) / 7.5 mL in 1 BOTTLE, DROPPER
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciprofloxacin hydrochloride; dexamethasone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCilodex ear dropsDE Pharmaceuticals
- CanadaCIPRODEXNOVARTIS PHARMACEUTICALS CANADA INC
- GermanyCilodexInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- FranceCILOXADEX 3 mg/1 mg par mL, suspension pour instillation auriculaireINFECTOPHARM ARZNEIMITTEL UND CONSILIUM (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Cyprus · Ciprofloxacin/Dexamethasone Rafarm
- Germany · Cilodex
- Denmark · Cilodex
- France · Ciloxadex, Sonixal
- United Kingdom (Northern Ireland) · Ciprofloxacin/Dexamethasone Aspire Pharma, Ciprofloxacin/Dexamethasone Infectopharm
- Greece · Ciprofloxacin+dexamethasone Rafarm
- Italy · Cilodex, Nisegal
- Portugal · Otifix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfc29b19-022c-4e3a-8187-89d48f5f63da GET /v1/drugs/cfc29b19-022c-4e3a-8187-89d48f5f63da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "AURICULAR (OTIC)",
"source": "ndc",
"strength": "3; 1",
"substance": "CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE",
"productndc": "62756-427",
"dosage_form": "SUSPENSION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "ANDA210470",
"marketing_category": "ANDA"
}See everything about ciprofloxacin hydrochloride; dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.